Calendar

Financial releases

Date Title  
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , Sept. 10, 2021 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.  The cash dividend is payable November 15, 2021 to stockholders of record at the close of business on October 15, 2021 .
Toggle Summary AbbVie to Present at the Morgan Stanley Healthcare Conference
NORTH CHICAGO, Ill. , Sept. 9, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Morgan Stanley Virtual 19th Annual Global Healthcare Conference on Wednesday, September 15, 2021 . Richard A. Gonzalez , chairman and chief executive officer, Michael Severino , M.D., vice chairman and
Toggle Summary AbbVie Reports Second-Quarter 2021 Financial Results
- Reports Second-Quarter Diluted EPS of $0.42 on a GAAP Basis; Adjusted Diluted EPS of $3.11 - Delivers Second-Quarter Net Revenues of $13.959 Billion, an Increase of 33.9 Percent on a Reported Basis - Second-Quarter Global Net Revenues from the Immunology Portfolio Were $6.120 Billion, an Increase
Toggle Summary AbbVie to Host Second-Quarter 2021 Earnings Conference Call
NORTH CHICAGO, Ill. , July 7, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its second-quarter 2021 financial results on Friday, July 30, 2021 , before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time .
Toggle Summary AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill. , June 17, 2021 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.  The cash dividend is payable August 16, 2021 to stockholders of record at the close of business on July 15, 2021 .
Toggle Summary AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
NORTH CHICAGO, Ill. , June 2, 2021 /PRNewswire/ --  AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 42 nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial
Toggle Summary AbbVie to Present at Bernstein's 37th Annual Strategic Decisions Conference
NORTH CHICAGO, Ill. , May 26, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in Bernstein's 37 th Annual Strategic Decisions Conference on Wednesday, June 2, 2021 . Michael Severino , M.D., vice chairman and president, and Robert A. Michael , executive vice president and chief financial
Toggle Summary AbbVie to Present at the UBS Global Healthcare Virtual Conference
NORTH CHICAGO, Ill. , May 20, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer, and
Toggle Summary AbbVie to Present at the RBC Capital Markets Global Healthcare Conference
NORTH CHICAGO, Ill. , May 12, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the RBC Capital Markets Global Healthcare Conference on Tuesday, May 18, 2021 . Michael Severino , M.D., vice chairman and president, Robert A. Michael , executive vice president and chief financial officer,
Toggle Summary AbbVie Reports First-Quarter 2021 Financial Results
- Reports First-Quarter Diluted EPS of $1.99 on a GAAP Basis; Adjusted Diluted EPS of $2.95 - Delivers First-Quarter Net Revenues of $13.010 Billion on a GAAP Basis, an Increase of 51.0 Percent on a Reported Basis; Adjusted Net Revenues Were $12.935 Billion - First-Quarter Global Net Revenues from